Samyak International Ltd (530025)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Samyak International's revenue was ₹11.9 Cr (+34.8% year on year, +14.6% on the previous quarter), and net profit ₹0.9 Cr (against a loss a year earlier); the operating margin was 14.3%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹11.9 | +34.8% | +14.6% |
| Operating profit | ₹1.7 | +34.6% | — |
| Net profit | ₹0.9 | from loss | from loss |
| EPS (₹) | 1.16 | from loss | from loss |
| Operating margin | 14.3% | — | — |
📢 Recent Corporate Announcements
Samyak International has secured listing approval from BSE Ltd for 40,00,000 equity shares issued on a preferential basis. The shares were allotted at an issue price of Rs 17 per share (face value Rs 10 plus Rs 7 premium), amounting to a total fundraise of Rs 6.80 crore. This infusion is substantial, representing nearly 49% of the company's current market capitalization of Rs 14 crore. The shares will be admitted to trading upon depository credit confirmation from NSDL and CDSL.
- Received BSE listing approval for 40,00,000 equity shares on October 07, 2026
- Shares issued at Rs 17 each (Rs 10 face value plus Rs 7 premium)
- Total preferential issue size of Rs 6.80 crore
- Issued to promoters and non-promoters/other persons via private placement
- Trading admission pending depository credit confirmation from NSDL/CDSL
Samyak International announced shareholder approval via ordinary resolution at its AGM on September 30, 2026, to alter Clause V of its Memorandum of Association. The company's authorised share capital has been increased from ₹16,00,00,000 to ₹25,00,00,000, divided into 2.5 crore equity shares of face value ₹10 each. The amendment is subject to approval from the Registrar of Companies (RoC). This expansion typically creates headroom for potential future equity issuance or corporate actions.
- Authorised share capital increased from ₹16,00,00,000 to ₹25,00,00,000
- Equity share count under authorised capital raised from 1,60,00,000 to 2,50,00,000 shares of ₹10 face value each
- Approval granted by shareholders at the AGM held on September 30, 2026
- Final implementation is subject to approval from the concerned RoC
Samyak International has been declared the Successful Resolution Applicant for Shree Uttam Food Products (India) Private Limited under the Corporate Insolvency Resolution Process (CIRP). The company submitted its final resolution plan on July 23, 2026, which was subsequently approved by the Committee of Creditors (CoC) with the requisite majority on September 25, 2026. The acquisition financial terms, resolution plan value, and payment structure were not disclosed in the filing. This acquisition targets the food products sector, contrasting with Samyak's FY26 TTM revenue of ₹42.33 Cr and market cap of ₹14 Cr.
- Declared Successful Resolution Applicant by the CoC on 25/09/2026
- Final Resolution Plan was submitted on 23/07/2026 pursuant to RFRP
- Target entity is Shree Uttam Food Products (India) Private Limited
- Resolution plan value and acquisition cost: not disclosed
Samyak International has approved the preferential allotment of 40,00,000 equity shares and 40,00,000 convertible warrants at an issue price of ₹17 per unit. The company has received 100% consideration for the equity shares (₹6.80 crore) and a 25% upfront subscription for the warrants (₹1.70 crore), totaling an immediate cash inflow of ₹8.50 crore. The remaining 75% for warrants (₹5.10 crore) is payable upon exercise within 18 months. The total potential issue size of ₹13.60 crore represents approximately 97% of the company's current market capitalization of ₹14 crore.
- Allotted 40,00,000 equity shares of ₹10 face value at ₹17 each (including ₹7 premium), raising ₹6.80 crore in full.
- Allotted 40,00,000 warrants convertible into equal equity shares at ₹17 each, receiving ₹1.70 crore (25% upfront).
- Total potential fundraise aggregates to ₹13.60 crore across equity shares and warrants.
- Allottees include promoters (Sudhir Jain, Sunit Jain, Neha Jain, Samyak Jain, Virendra Capital) and non-promoter corporate investors.
- Warrant holders have an 18-month conversion window to pay the remaining 75% balance.
Samyak International reported standalone revenue from operations of ₹709.33 Lakhs (₹7.09 Cr) for the quarter ended June 30, 2026, up 144.5% YoY from ₹290.11 Lakhs in Q1 FY26. Standalone net profit stood at ₹52.91 Lakhs, turning around from a net loss of ₹142.89 Lakhs in Q4 FY26 and rising from ₹3.39 Lakhs in Q1 FY26. Standalone EPS improved to ₹0.66 compared to ₹-1.79 in the previous quarter. Its subsidiary, Keti Highway Developers Pvt Ltd, contributed ₹484.65 Lakhs in revenue and ₹33.17 Lakhs in PAT.
- Standalone revenue from operations increased 144.5% YoY to ₹709.33 Lakhs vs ₹290.11 Lakhs in Q1 FY26
- Standalone PAT rebounded to ₹52.91 Lakhs vs a net loss of ₹142.89 Lakhs in Q4 FY26
- Standalone Basic EPS reported at ₹0.66 for the quarter ended June 30, 2026
- Subsidiary Keti Highway Developers posted total revenue of ₹484.65 Lakhs and net profit of ₹33.17 Lakhs
Samyak International reported its Q1 FY27 (quarter ended June 30, 2026) standalone revenue from operations of Rs 709.33 Lakhs (Rs 7.09 Cr), up 144.5% YoY compared to Rs 290.11 Lakhs in Q1 FY26. Standalone net profit stood at Rs 52.91 Lakhs, marking a recovery from a net loss of Rs 142.89 Lakhs in the preceding quarter (Q4 FY26). Standalone Basic EPS for the quarter improved to Rs 0.66 from Rs 0.08 in the year-ago period. On a consolidated basis, the company recorded an EPS of Rs 1.16 for the quarter.
- Standalone revenue from operations surged to Rs 709.33 Lakhs in Q1 FY27 from Rs 290.11 Lakhs in Q1 FY26
- Standalone net profit reached Rs 52.91 Lakhs, turning around from a loss of Rs 142.89 Lakhs in Q4 FY26
- Consolidated EPS stood at Rs 1.16 for the quarter ended June 30, 2026
- Subsidiary Keti Highway Developers contributed Rs 484.65 Lakhs in revenue and Rs 33.17 Lakhs in PAT
Samyak International has scheduled a board meeting for August 14, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026. The company, a micro-cap with a market capitalization of Rs 14 Cr, reported a TTM revenue of Rs 42 Cr but faced a significant net loss of Rs 2.49 Cr in the most recent quarter (March 2026). Investors will be monitoring these results to see if the company can return to the marginal profitability seen in FY26 (Rs 0.24 Cr). The trading window has been closed since July 01, 2026, in compliance with insider trading regulations.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
- Trading window closed since July 01, 2026, for all designated persons
- Company reported a net loss of Rs 2.49 Cr in the previous quarter ended March 2026
- Market capitalization is currently Rs 14 Cr against a TTM revenue of Rs 42 Cr
- Promoter holding remains stable but low at 22.35% as of June 2026
Samyak International has received in-principle approval from BSE for a significant preferential issue. The plan includes the issuance of 40,00,000 equity shares and 40,00,000 convertible warrants, both at a face value of Rs 10. Given the company's small market capitalization of Rs 14 crore, this total issuance of 80 lakh units represents a massive equity expansion. The funds are intended to be raised from both promoters and non-promoter groups, which is critical as the company reported a TTM net loss of Rs 2 crore.
- Issuance of 40,00,000 equity shares of Rs 10 each on a preferential basis
- Issuance of 40,00,000 warrants convertible into equity shares to promoters and non-promoters
- In-principle approval received from BSE Ltd on August 05, 2026
- Potential total issuance of 80 lakh shares represents approximately 100% dilution of current equity base
- Approval granted under Regulation 28(1) of SEBI Listing Regulations
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.